Correlation analysis of EAT GIPR and EAT GCGR with genes involved in FFA metabolism and adipogenesis
Glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
a) Fatty acid metabolism genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACAD11 | Acetyl-CoA dehydrogenases | Promote FFA oxidation | −0.7507 | <0.0001 |
ACADS | −0.5371 | 0.0013 | ||
ACADVL | −0.5531 | 0.0008 | ||
ACADM | −0.5551 | 0.0008 | ||
ACAD9 | −0.5899 | 0.0003 | ||
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | −0.3797 | 0.0293 |
ACSBG2 | 0.6129 | 0.0001 | ||
ACSL1 | −0.4024 | 0.0203 | ||
ACSL3 | −0.5575 | 0.0008 | ||
ACSL4 | −0.6795 | <0.0001 | ||
ACSL5 | −0.5348 | 0.0013 | ||
ACSL6 | 0.5641 | 0.0006 | ||
ACSM4 | 0.5674 | 0.0006 | ||
ACSM5 | −0.4469 | 0.0091 | ||
ACOT1 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | −0.4368 | 0.011 |
ACOT12 | 0.3907 | 0.0246 | ||
ACOT6 | 0.4225 | 0.0143 | ||
ACOT7 | −0.735 | <0.0001 | ||
ACOT8 | −0.6153 | <0.0001 | ||
ACOT9 | −0.7035 | <0.0001 | ||
ACOX1 | Acyl-CoA oxidases | The first enzyme of the fatty acid beta-oxidation pathway | −0.5194 | 0.002 |
ACOX2 | Involved in the degradation of long branched fatty acids | −0.515 | 0.0022 | |
ACOX3 | Involved in the desaturation of 2-methyl-branched fatty acids in peroxisomes | −0.6116 | 0.0002 | |
ACAT1 | Acetyl-CoA transferases | Catalyses the last step of the mitochondrial beta-oxidation pathway | −0.497 | 0.0033 |
ACAA1 | Involved in the beta-oxidation system of the peroxisomes | −0.6186 | 0.0001 | |
ACAA2 | Catalyses the last step of the mitochondrial fatty acid beta-oxidation | −0.5374 | 0.0013 | |
ACAT2 | Intracellular cholesterol esterification | −0.736 | <0.0001 | |
CPT1A | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.6013 | 0.0002 |
CPT1B | −0.5074 | 0.0026 | ||
CPT1C | −0.4131 | 0.0169 | ||
CPT2 | −0.6003 | 0.0002 | ||
CRAT | −0.5916 | 0.0003 | ||
CROT | −0.5729 | 0.0005 | ||
FABP1 | Facilitate FFA transport across membranes | 0.538 | 0.0012 | |
SLC27A1 | −0.6785 | <0.0001 | ||
SLC27A3 | −0.7035 | <0.0001 | ||
SLC27A4 | −0.478 | 0.0003 | ||
SLC27A5 | −0.4923 | 0.0036 | ||
FABP7 | Cytoplasmatic FFA transport proteins | 0.5572 | 0.0008 | |
FABP2 | 0.5104 | 0.0024 | ||
FABP4 | −0.5084 | 0.0025 | ||
FABP12 | 0.6093 | 0.0002 | ||
FABP5 | −0.4686 | 0.006 | ||
PRKAA2 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | −0.6355 | <0.0001 |
PRKAB1 | Regulatory B1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.8456 | <0.0001 | |
PRKAB2 | Regulatory B2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.7574 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.6537 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | −0.5525 | 0.0009 | |
PRKAG1 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.734 | <0.0001 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.4559 | 0.0077 | |
ALDH2 | Other fatty acid metabolism genes | Oxidizes aldehydes to generate carboxylic acids for use | −0.4078 | 0.0185 |
DECR1 | Accessory enzymes that participate in the beta-oxidation and metabolism of unsaturated fatty enoyl-CoA esters | −0.5792 | 0.0004 | |
ECHS1 | Involved in mitochondrial fatty acid beta-oxidation pathway | −0.5137 | 0.0022 | |
ECI2 | Mitochondrial enzyme involved in beta-oxidation of unsaturated fatty acids | −0.6487 | <0.0001 | |
HADHA | Catalyses the last three steps of mitochondrial beta-oxidation of long chain fatty acids | −0.4682 | 0.006 | |
MCEE | Involved in the degradation of odd chain-length fatty acids | −0.5745 | 0.0005 | |
MUT | −0.5805 | 0.0004 | ||
PPA1 | Catalyses the hydrolysis of pyrophosphate to inorganic phosphate | −0.5451 | 0.001 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.6344 | <0.0001 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.4335 | 0.0117 | |
GK2 | Key enzyme in the regulation of glycerol uptake and metabolism | 0.5577 | 0.0007 | |
GPD1 | Synthesis of triglycerides | −0.5872 | 0.0003 | |
GPD2 | −0.3556 | 0.0423 | ||
BDH2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | −0.5254 | 0.0017 |
HMGCS1 | −0.7764 | <0.0001 | ||
OXCT2 | Involved in ketone body catabolism. | 0.3795 | 0.0294 | |
HMGCL | Catalyzes the final step of leucine degradation and plays a key role in ketone body formation. | −0.6511 | <0.0001 | |
Glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
a) Fatty acid metabolism genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACAD11 | Acetyl-CoA dehydrogenases | Promote FFA oxidation | −0.7507 | <0.0001 |
ACADS | −0.5371 | 0.0013 | ||
ACADVL | −0.5531 | 0.0008 | ||
ACADM | −0.5551 | 0.0008 | ||
ACAD9 | −0.5899 | 0.0003 | ||
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | −0.3797 | 0.0293 |
ACSBG2 | 0.6129 | 0.0001 | ||
ACSL1 | −0.4024 | 0.0203 | ||
ACSL3 | −0.5575 | 0.0008 | ||
ACSL4 | −0.6795 | <0.0001 | ||
ACSL5 | −0.5348 | 0.0013 | ||
ACSL6 | 0.5641 | 0.0006 | ||
ACSM4 | 0.5674 | 0.0006 | ||
ACSM5 | −0.4469 | 0.0091 | ||
ACOT1 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | −0.4368 | 0.011 |
ACOT12 | 0.3907 | 0.0246 | ||
ACOT6 | 0.4225 | 0.0143 | ||
ACOT7 | −0.735 | <0.0001 | ||
ACOT8 | −0.6153 | <0.0001 | ||
ACOT9 | −0.7035 | <0.0001 | ||
ACOX1 | Acyl-CoA oxidases | The first enzyme of the fatty acid beta-oxidation pathway | −0.5194 | 0.002 |
ACOX2 | Involved in the degradation of long branched fatty acids | −0.515 | 0.0022 | |
ACOX3 | Involved in the desaturation of 2-methyl-branched fatty acids in peroxisomes | −0.6116 | 0.0002 | |
ACAT1 | Acetyl-CoA transferases | Catalyses the last step of the mitochondrial beta-oxidation pathway | −0.497 | 0.0033 |
ACAA1 | Involved in the beta-oxidation system of the peroxisomes | −0.6186 | 0.0001 | |
ACAA2 | Catalyses the last step of the mitochondrial fatty acid beta-oxidation | −0.5374 | 0.0013 | |
ACAT2 | Intracellular cholesterol esterification | −0.736 | <0.0001 | |
CPT1A | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.6013 | 0.0002 |
CPT1B | −0.5074 | 0.0026 | ||
CPT1C | −0.4131 | 0.0169 | ||
CPT2 | −0.6003 | 0.0002 | ||
CRAT | −0.5916 | 0.0003 | ||
CROT | −0.5729 | 0.0005 | ||
FABP1 | Facilitate FFA transport across membranes | 0.538 | 0.0012 | |
SLC27A1 | −0.6785 | <0.0001 | ||
SLC27A3 | −0.7035 | <0.0001 | ||
SLC27A4 | −0.478 | 0.0003 | ||
SLC27A5 | −0.4923 | 0.0036 | ||
FABP7 | Cytoplasmatic FFA transport proteins | 0.5572 | 0.0008 | |
FABP2 | 0.5104 | 0.0024 | ||
FABP4 | −0.5084 | 0.0025 | ||
FABP12 | 0.6093 | 0.0002 | ||
FABP5 | −0.4686 | 0.006 | ||
PRKAA2 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | −0.6355 | <0.0001 |
PRKAB1 | Regulatory B1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.8456 | <0.0001 | |
PRKAB2 | Regulatory B2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.7574 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.6537 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | −0.5525 | 0.0009 | |
PRKAG1 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.734 | <0.0001 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.4559 | 0.0077 | |
ALDH2 | Other fatty acid metabolism genes | Oxidizes aldehydes to generate carboxylic acids for use | −0.4078 | 0.0185 |
DECR1 | Accessory enzymes that participate in the beta-oxidation and metabolism of unsaturated fatty enoyl-CoA esters | −0.5792 | 0.0004 | |
ECHS1 | Involved in mitochondrial fatty acid beta-oxidation pathway | −0.5137 | 0.0022 | |
ECI2 | Mitochondrial enzyme involved in beta-oxidation of unsaturated fatty acids | −0.6487 | <0.0001 | |
HADHA | Catalyses the last three steps of mitochondrial beta-oxidation of long chain fatty acids | −0.4682 | 0.006 | |
MCEE | Involved in the degradation of odd chain-length fatty acids | −0.5745 | 0.0005 | |
MUT | −0.5805 | 0.0004 | ||
PPA1 | Catalyses the hydrolysis of pyrophosphate to inorganic phosphate | −0.5451 | 0.001 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.6344 | <0.0001 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.4335 | 0.0117 | |
GK2 | Key enzyme in the regulation of glycerol uptake and metabolism | 0.5577 | 0.0007 | |
GPD1 | Synthesis of triglycerides | −0.5872 | 0.0003 | |
GPD2 | −0.3556 | 0.0423 | ||
BDH2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | −0.5254 | 0.0017 |
HMGCS1 | −0.7764 | <0.0001 | ||
OXCT2 | Involved in ketone body catabolism. | 0.3795 | 0.0294 | |
HMGCL | Catalyzes the final step of leucine degradation and plays a key role in ketone body formation. | −0.6511 | <0.0001 | |
b) Adipogenis genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ADIPOQ | Adipokines and hormones | Involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic, and anti-inflammatory activities | −0.548 | 0.001 |
ANGPT2 | An inducer of fat uptake in adipose tissue for prevention of ectopic lipid deposition | −0.538 | 0.001 | |
RETN | A feedback regulator of adipogenesis | 0.438 | 0.011 | |
AGT | Encodes for angiotensinogen precursor angiotensin | −0.540 | 0.001 | |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.569 | 0.001 | |
FASN | PPARγ TARGETS | Fatty acid synthetase that catalyses the de novo biosynthesis of long-chain saturated fatty acids | −0.368 | 0.035 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.434 | 0.012 | |
FABP4 | Lipid transport protein in adipocytes | −0.508 | 0.003 | |
ADRB2 | Anti-adipogenesis | Beta-2-adrenergic receptor with lipolytic activity | −0.482 | 0.005 |
CDKN1A | A cyclin-dependent kinase inhibitor | −0.510 | 0.002 | |
CDKN1B | −0.678 | <0.0001 | ||
DDIT3 | A member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors that block adipogenesis | −0.731 | <0.0001 | |
FOXO1 | Transcription factor that inhibits lipogenesis | −0.483 | 0.004 | |
HES1 | −0.670 | <0.0001 | ||
LRP5 | A transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis | −0.492 | 0.004 | |
NCOR2 | Inhibits adipogenic differentiation by binding to PPARγ and represses the expression of PPARγ target genes | −0.743 | <0.0001 | |
SHH | Inhibits adipocyte differentiation | 0.565 | 0.001 | |
RUNX1T1 | Recruits a range of co-repressors to acts as a negative regulator of adipogenesis | −0.636 | <0.0001 | |
SIRT1 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.778 | <0.0001 | |
SIRT2 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.626 | <0.0001 | |
TAZ | A transcriptional co-repressor of PPARγ that attenuates adipogenesis | −0.738 | <0.0001 | |
WNT3A | Inhibitor of adipogenesis | 0.497 | 0.003 | |
VDR | Unliganded VDR can activate adipogenesis through increased lipid accumulation | −0.532 | 0.001 | |
TCF7L2 | Adipose specific knockout of Tcf7l2 leads to adipocyte hypertrophy and impaired lipolysis | −0.397 | 0.022 | |
TSC22D3 | Inhibitor of the adipogenic master regulator PPARγ | −0.657 | <0.0001 | |
NCOA2 | Anti-BAT tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | −0.704 | <0.0001 |
TWIST1 | Inhibit UCP-1 in brown adipocytes | −0.385 | 0.027 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | −0.703 | <0.0001 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.537 | 0.001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | −0.558 | 0.001 |
KLF2 | Negative regulator of adipogenesis | −0.568 | 0.001 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | −0.567 | 0.001 | |
AXIN1 | Pro-adipogenesis | Promoter of adipocyte differentiation | −0.799 | <0.0001 |
CCND1 | −0.458 | 0.007 | ||
CDK4 | −0.817 | <0.0001 | ||
CEBPA | −0.579 | 0.0001 | ||
CEBPB | −0.553 | 0.001 | ||
CEBPD | −0.369 | 0.034 | ||
E2F1 | −0.515 | 0.002 | ||
FGF1 | −0.450 | 0.009 | ||
FGF2 | −0.670 | <0.0001 | ||
IRS2 | 0.560 | 0.001 | ||
SFRP1 | −0.354 | 0.043 | ||
SLC2A4 | −0.369 | 0.034 | ||
LMNA | −0.810 | <0.0001 | ||
PPARG | −0.506 | 0.003 | ||
RXRA | Implicated in the development of dysfunctional white adipose tissue | −0.700 | <0.0001 | |
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.693 | <0.0001 |
DIO2 | Involved in the transcriptional regulation of brown adipogenesis | −0.791 | <0.0001 | |
INSR | Regulates metabolism in brown adipose tissue | −0.411 | 0.017 | |
IRS1 | Involved in the differentiation of brown adipocytes | −0.449 | 0.009 | |
NRF1 | Involved in brown adipose tissue thermogenic adaptation | −0.775 | <0.0001 | |
MAPK14 | Controls brown adipocyte differentiation | −0.715 | <0.0001 | |
PPARA | Regulators of brown adipogenesis/metabolism | −0.619 | 0.0001 | |
PPARD | −0.740 | <0.0001 | ||
PPARGC1B | −0.389 | 0.025 | ||
PRDM16 | −0.525 | 0.002 | ||
WNT5A | −0.458 | 0.007 | ||
SRC | Controls brown fat thermogenesis | −0.412 | 0.017 | |
SIRT3 | −0.745 | <0.0001 | ||
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | −0.521 | 0.002 |
BMP2 | −0.512 | 0.002 | ||
BMP4 | −0.709 | <0.0001 | ||
CEBPA | Required for differentiation of white adipocytes | −0.579 | 0.0004 | |
b) Adipogenis genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ADIPOQ | Adipokines and hormones | Involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic, and anti-inflammatory activities | −0.548 | 0.001 |
ANGPT2 | An inducer of fat uptake in adipose tissue for prevention of ectopic lipid deposition | −0.538 | 0.001 | |
RETN | A feedback regulator of adipogenesis | 0.438 | 0.011 | |
AGT | Encodes for angiotensinogen precursor angiotensin | −0.540 | 0.001 | |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.569 | 0.001 | |
FASN | PPARγ TARGETS | Fatty acid synthetase that catalyses the de novo biosynthesis of long-chain saturated fatty acids | −0.368 | 0.035 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.434 | 0.012 | |
FABP4 | Lipid transport protein in adipocytes | −0.508 | 0.003 | |
ADRB2 | Anti-adipogenesis | Beta-2-adrenergic receptor with lipolytic activity | −0.482 | 0.005 |
CDKN1A | A cyclin-dependent kinase inhibitor | −0.510 | 0.002 | |
CDKN1B | −0.678 | <0.0001 | ||
DDIT3 | A member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors that block adipogenesis | −0.731 | <0.0001 | |
FOXO1 | Transcription factor that inhibits lipogenesis | −0.483 | 0.004 | |
HES1 | −0.670 | <0.0001 | ||
LRP5 | A transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis | −0.492 | 0.004 | |
NCOR2 | Inhibits adipogenic differentiation by binding to PPARγ and represses the expression of PPARγ target genes | −0.743 | <0.0001 | |
SHH | Inhibits adipocyte differentiation | 0.565 | 0.001 | |
RUNX1T1 | Recruits a range of co-repressors to acts as a negative regulator of adipogenesis | −0.636 | <0.0001 | |
SIRT1 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.778 | <0.0001 | |
SIRT2 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.626 | <0.0001 | |
TAZ | A transcriptional co-repressor of PPARγ that attenuates adipogenesis | −0.738 | <0.0001 | |
WNT3A | Inhibitor of adipogenesis | 0.497 | 0.003 | |
VDR | Unliganded VDR can activate adipogenesis through increased lipid accumulation | −0.532 | 0.001 | |
TCF7L2 | Adipose specific knockout of Tcf7l2 leads to adipocyte hypertrophy and impaired lipolysis | −0.397 | 0.022 | |
TSC22D3 | Inhibitor of the adipogenic master regulator PPARγ | −0.657 | <0.0001 | |
NCOA2 | Anti-BAT tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | −0.704 | <0.0001 |
TWIST1 | Inhibit UCP-1 in brown adipocytes | −0.385 | 0.027 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | −0.703 | <0.0001 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.537 | 0.001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | −0.558 | 0.001 |
KLF2 | Negative regulator of adipogenesis | −0.568 | 0.001 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | −0.567 | 0.001 | |
AXIN1 | Pro-adipogenesis | Promoter of adipocyte differentiation | −0.799 | <0.0001 |
CCND1 | −0.458 | 0.007 | ||
CDK4 | −0.817 | <0.0001 | ||
CEBPA | −0.579 | 0.0001 | ||
CEBPB | −0.553 | 0.001 | ||
CEBPD | −0.369 | 0.034 | ||
E2F1 | −0.515 | 0.002 | ||
FGF1 | −0.450 | 0.009 | ||
FGF2 | −0.670 | <0.0001 | ||
IRS2 | 0.560 | 0.001 | ||
SFRP1 | −0.354 | 0.043 | ||
SLC2A4 | −0.369 | 0.034 | ||
LMNA | −0.810 | <0.0001 | ||
PPARG | −0.506 | 0.003 | ||
RXRA | Implicated in the development of dysfunctional white adipose tissue | −0.700 | <0.0001 | |
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.693 | <0.0001 |
DIO2 | Involved in the transcriptional regulation of brown adipogenesis | −0.791 | <0.0001 | |
INSR | Regulates metabolism in brown adipose tissue | −0.411 | 0.017 | |
IRS1 | Involved in the differentiation of brown adipocytes | −0.449 | 0.009 | |
NRF1 | Involved in brown adipose tissue thermogenic adaptation | −0.775 | <0.0001 | |
MAPK14 | Controls brown adipocyte differentiation | −0.715 | <0.0001 | |
PPARA | Regulators of brown adipogenesis/metabolism | −0.619 | 0.0001 | |
PPARD | −0.740 | <0.0001 | ||
PPARGC1B | −0.389 | 0.025 | ||
PRDM16 | −0.525 | 0.002 | ||
WNT5A | −0.458 | 0.007 | ||
SRC | Controls brown fat thermogenesis | −0.412 | 0.017 | |
SIRT3 | −0.745 | <0.0001 | ||
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | −0.521 | 0.002 |
BMP2 | −0.512 | 0.002 | ||
BMP4 | −0.709 | <0.0001 | ||
CEBPA | Required for differentiation of white adipocytes | −0.579 | 0.0004 | |
Glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
c) Fatty acid metabolism genes and glucagon receptor (GCGR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACADSB | Acyl-CoA dehydrohgenases | It has the greatest activity towards the short branched chain acyl-CoA derivative | 0.3753 | 0.0314 |
EHHADH | One of the four enzymes of the peroxisomal beta-oxidation pathway | −0.3693 | 0.0344 | |
ACADL | One of the four enzymes that catalyse the initial step of mitochondrial beta-oxidation of straight-chain fatty acid | 0.3815 | 0.0285 | |
ACAD10 | Involved in the beta-oxidation of fatty acids in mitochondria | 0.4278 | 0.00130 | |
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | 0.3850 | 0.0269 |
ACSBG2 | 0.8244 | <0.0001 | ||
ACSL6 | 0.3643 | 0.0371 | ||
ACSM3 | 0.7245 | <0.0001 | ||
ACSM4 | 0.8426 | <0.0001 | ||
ACOT12 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | 0.8235 | <0.0001 |
ACOT6 | 0.8001 | <0.0001 | ||
CROT | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.4649 | 0.0064 |
SLC27A3 | Facilitate FFA transport across membranes | 0.6557 | <0.0001 | |
FABP1 | Cytoplasmatic FFA transport proteins | 0.7942 | <0.0001 | |
FABP2 | 0.8285 | <0.0001 | ||
FABP12 | 0.7868 | <0.0001 | ||
FABP6 | 0.7830 | <0.0001 | ||
PRKAA1 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.5241 | 0.0017 |
PRKAA2 | AMP-activated, alpha 1 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.6581 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.8138 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | 0.5291 | 0.0015 | |
PRKAG3 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.4442 | 0.0096 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.9809 | <0.0287 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.5013 | 0.0030 |
HMGCS2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | 0.8085 | <0.0001 |
OXCT2 | Involeved in ketone body catabolism | 0.7908 | <0.0001 | |
Glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
c) Fatty acid metabolism genes and glucagon receptor (GCGR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACADSB | Acyl-CoA dehydrohgenases | It has the greatest activity towards the short branched chain acyl-CoA derivative | 0.3753 | 0.0314 |
EHHADH | One of the four enzymes of the peroxisomal beta-oxidation pathway | −0.3693 | 0.0344 | |
ACADL | One of the four enzymes that catalyse the initial step of mitochondrial beta-oxidation of straight-chain fatty acid | 0.3815 | 0.0285 | |
ACAD10 | Involved in the beta-oxidation of fatty acids in mitochondria | 0.4278 | 0.00130 | |
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | 0.3850 | 0.0269 |
ACSBG2 | 0.8244 | <0.0001 | ||
ACSL6 | 0.3643 | 0.0371 | ||
ACSM3 | 0.7245 | <0.0001 | ||
ACSM4 | 0.8426 | <0.0001 | ||
ACOT12 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | 0.8235 | <0.0001 |
ACOT6 | 0.8001 | <0.0001 | ||
CROT | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.4649 | 0.0064 |
SLC27A3 | Facilitate FFA transport across membranes | 0.6557 | <0.0001 | |
FABP1 | Cytoplasmatic FFA transport proteins | 0.7942 | <0.0001 | |
FABP2 | 0.8285 | <0.0001 | ||
FABP12 | 0.7868 | <0.0001 | ||
FABP6 | 0.7830 | <0.0001 | ||
PRKAA1 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.5241 | 0.0017 |
PRKAA2 | AMP-activated, alpha 1 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.6581 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.8138 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | 0.5291 | 0.0015 | |
PRKAG3 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.4442 | 0.0096 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.9809 | <0.0287 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.5013 | 0.0030 |
HMGCS2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | 0.8085 | <0.0001 |
OXCT2 | Involeved in ketone body catabolism | 0.7908 | <0.0001 | |
d) Adipogenesis genes and glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
RETN | Adipokines and hormones | A feedback regulator of adipogenesis | 0.6892 | <0.0001 |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.8425 | <0.0001 | |
HES1 | Anti-adipogenesis | Inhibits adipocyte differentiation | −0.4395 | 0.0105 |
DLK1 | 0.7219 | <0.0001 | ||
SHH | 0.8773 | <0.0001 | ||
TCF7L2 | 0.6788 | <0.0001 | ||
WNT1 | 0.8179 | <0.0001 | ||
WNT3A | 0.8289 | <0.0001 | ||
RUNX1T1 | −0.4275 | 0.0131 | ||
NCOA2 | Anti-brown adipose tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | 0.5221 | 0.0018 |
WNT10B | It blocks brown adipose tissue development and expression of UCP-1. | 0.7189 | <0.0001 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | 0.5211 | 0.0019 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.8780 | <0.0001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | 0.6982 | <0.0001 |
GATA3 | Involved in white browning | 0.4522 | 0.0082 | |
KLF2 | Negative regulator of adipogenesis | 0.4318 | 0.0121 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | 0.6765 | <0.0001 | |
IRS2 | Pro-adipogenesis | Promoter of adipocyte differentiation | 0.6517 | <0.0001 |
CEBPB | 0.4369 | 0.0110 | ||
FGF1 | 0.3830 | 0.0278 | ||
SFRP5 | 0.6130 | 0.0001 | ||
WNT5B | 0.3917 | 0.0242 | ||
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.4830 | 0.0044 |
FOXC2 | 0.8443 | <0.0001 | ||
MAPK14 | 0.3981 | 0.0218 | ||
PPARA | Regulators of brown adipogenesis/metabolism | 0.7383 | <0.0001 | |
PPARD | 0.8281 | <0.0001 | ||
PPARGC1A | 0.6832 | <0.0001 | ||
UCP-1 | 0.5635 | 0.0006 | ||
PRDM16 | 0.7189 | <0.0001 | ||
SRC | Controls brown fat thermogenesis | 0.4412 | 0.0102 | |
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | 0.5625 | <0.0007 |
KLF15 | 0.6768 | <0.0001 |
d) Adipogenesis genes and glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
RETN | Adipokines and hormones | A feedback regulator of adipogenesis | 0.6892 | <0.0001 |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.8425 | <0.0001 | |
HES1 | Anti-adipogenesis | Inhibits adipocyte differentiation | −0.4395 | 0.0105 |
DLK1 | 0.7219 | <0.0001 | ||
SHH | 0.8773 | <0.0001 | ||
TCF7L2 | 0.6788 | <0.0001 | ||
WNT1 | 0.8179 | <0.0001 | ||
WNT3A | 0.8289 | <0.0001 | ||
RUNX1T1 | −0.4275 | 0.0131 | ||
NCOA2 | Anti-brown adipose tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | 0.5221 | 0.0018 |
WNT10B | It blocks brown adipose tissue development and expression of UCP-1. | 0.7189 | <0.0001 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | 0.5211 | 0.0019 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.8780 | <0.0001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | 0.6982 | <0.0001 |
GATA3 | Involved in white browning | 0.4522 | 0.0082 | |
KLF2 | Negative regulator of adipogenesis | 0.4318 | 0.0121 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | 0.6765 | <0.0001 | |
IRS2 | Pro-adipogenesis | Promoter of adipocyte differentiation | 0.6517 | <0.0001 |
CEBPB | 0.4369 | 0.0110 | ||
FGF1 | 0.3830 | 0.0278 | ||
SFRP5 | 0.6130 | 0.0001 | ||
WNT5B | 0.3917 | 0.0242 | ||
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.4830 | 0.0044 |
FOXC2 | 0.8443 | <0.0001 | ||
MAPK14 | 0.3981 | 0.0218 | ||
PPARA | Regulators of brown adipogenesis/metabolism | 0.7383 | <0.0001 | |
PPARD | 0.8281 | <0.0001 | ||
PPARGC1A | 0.6832 | <0.0001 | ||
UCP-1 | 0.5635 | 0.0006 | ||
PRDM16 | 0.7189 | <0.0001 | ||
SRC | Controls brown fat thermogenesis | 0.4412 | 0.0102 | |
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | 0.5625 | <0.0007 |
KLF15 | 0.6768 | <0.0001 |
Table reports existing positive and negative correlations of glucose-dependent insulinotropic peptide receptor (GIPR) and glucagon receptor (GCGR) with genes involved in fatty acid metabolism and adipogenesis.
Spearman correlation coefficients and corresponding P value are reported.
Correlation analysis of EAT GIPR and EAT GCGR with genes involved in FFA metabolism and adipogenesis
Glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
a) Fatty acid metabolism genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACAD11 | Acetyl-CoA dehydrogenases | Promote FFA oxidation | −0.7507 | <0.0001 |
ACADS | −0.5371 | 0.0013 | ||
ACADVL | −0.5531 | 0.0008 | ||
ACADM | −0.5551 | 0.0008 | ||
ACAD9 | −0.5899 | 0.0003 | ||
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | −0.3797 | 0.0293 |
ACSBG2 | 0.6129 | 0.0001 | ||
ACSL1 | −0.4024 | 0.0203 | ||
ACSL3 | −0.5575 | 0.0008 | ||
ACSL4 | −0.6795 | <0.0001 | ||
ACSL5 | −0.5348 | 0.0013 | ||
ACSL6 | 0.5641 | 0.0006 | ||
ACSM4 | 0.5674 | 0.0006 | ||
ACSM5 | −0.4469 | 0.0091 | ||
ACOT1 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | −0.4368 | 0.011 |
ACOT12 | 0.3907 | 0.0246 | ||
ACOT6 | 0.4225 | 0.0143 | ||
ACOT7 | −0.735 | <0.0001 | ||
ACOT8 | −0.6153 | <0.0001 | ||
ACOT9 | −0.7035 | <0.0001 | ||
ACOX1 | Acyl-CoA oxidases | The first enzyme of the fatty acid beta-oxidation pathway | −0.5194 | 0.002 |
ACOX2 | Involved in the degradation of long branched fatty acids | −0.515 | 0.0022 | |
ACOX3 | Involved in the desaturation of 2-methyl-branched fatty acids in peroxisomes | −0.6116 | 0.0002 | |
ACAT1 | Acetyl-CoA transferases | Catalyses the last step of the mitochondrial beta-oxidation pathway | −0.497 | 0.0033 |
ACAA1 | Involved in the beta-oxidation system of the peroxisomes | −0.6186 | 0.0001 | |
ACAA2 | Catalyses the last step of the mitochondrial fatty acid beta-oxidation | −0.5374 | 0.0013 | |
ACAT2 | Intracellular cholesterol esterification | −0.736 | <0.0001 | |
CPT1A | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.6013 | 0.0002 |
CPT1B | −0.5074 | 0.0026 | ||
CPT1C | −0.4131 | 0.0169 | ||
CPT2 | −0.6003 | 0.0002 | ||
CRAT | −0.5916 | 0.0003 | ||
CROT | −0.5729 | 0.0005 | ||
FABP1 | Facilitate FFA transport across membranes | 0.538 | 0.0012 | |
SLC27A1 | −0.6785 | <0.0001 | ||
SLC27A3 | −0.7035 | <0.0001 | ||
SLC27A4 | −0.478 | 0.0003 | ||
SLC27A5 | −0.4923 | 0.0036 | ||
FABP7 | Cytoplasmatic FFA transport proteins | 0.5572 | 0.0008 | |
FABP2 | 0.5104 | 0.0024 | ||
FABP4 | −0.5084 | 0.0025 | ||
FABP12 | 0.6093 | 0.0002 | ||
FABP5 | −0.4686 | 0.006 | ||
PRKAA2 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | −0.6355 | <0.0001 |
PRKAB1 | Regulatory B1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.8456 | <0.0001 | |
PRKAB2 | Regulatory B2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.7574 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.6537 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | −0.5525 | 0.0009 | |
PRKAG1 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.734 | <0.0001 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.4559 | 0.0077 | |
ALDH2 | Other fatty acid metabolism genes | Oxidizes aldehydes to generate carboxylic acids for use | −0.4078 | 0.0185 |
DECR1 | Accessory enzymes that participate in the beta-oxidation and metabolism of unsaturated fatty enoyl-CoA esters | −0.5792 | 0.0004 | |
ECHS1 | Involved in mitochondrial fatty acid beta-oxidation pathway | −0.5137 | 0.0022 | |
ECI2 | Mitochondrial enzyme involved in beta-oxidation of unsaturated fatty acids | −0.6487 | <0.0001 | |
HADHA | Catalyses the last three steps of mitochondrial beta-oxidation of long chain fatty acids | −0.4682 | 0.006 | |
MCEE | Involved in the degradation of odd chain-length fatty acids | −0.5745 | 0.0005 | |
MUT | −0.5805 | 0.0004 | ||
PPA1 | Catalyses the hydrolysis of pyrophosphate to inorganic phosphate | −0.5451 | 0.001 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.6344 | <0.0001 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.4335 | 0.0117 | |
GK2 | Key enzyme in the regulation of glycerol uptake and metabolism | 0.5577 | 0.0007 | |
GPD1 | Synthesis of triglycerides | −0.5872 | 0.0003 | |
GPD2 | −0.3556 | 0.0423 | ||
BDH2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | −0.5254 | 0.0017 |
HMGCS1 | −0.7764 | <0.0001 | ||
OXCT2 | Involved in ketone body catabolism. | 0.3795 | 0.0294 | |
HMGCL | Catalyzes the final step of leucine degradation and plays a key role in ketone body formation. | −0.6511 | <0.0001 | |
Glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
a) Fatty acid metabolism genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACAD11 | Acetyl-CoA dehydrogenases | Promote FFA oxidation | −0.7507 | <0.0001 |
ACADS | −0.5371 | 0.0013 | ||
ACADVL | −0.5531 | 0.0008 | ||
ACADM | −0.5551 | 0.0008 | ||
ACAD9 | −0.5899 | 0.0003 | ||
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | −0.3797 | 0.0293 |
ACSBG2 | 0.6129 | 0.0001 | ||
ACSL1 | −0.4024 | 0.0203 | ||
ACSL3 | −0.5575 | 0.0008 | ||
ACSL4 | −0.6795 | <0.0001 | ||
ACSL5 | −0.5348 | 0.0013 | ||
ACSL6 | 0.5641 | 0.0006 | ||
ACSM4 | 0.5674 | 0.0006 | ||
ACSM5 | −0.4469 | 0.0091 | ||
ACOT1 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | −0.4368 | 0.011 |
ACOT12 | 0.3907 | 0.0246 | ||
ACOT6 | 0.4225 | 0.0143 | ||
ACOT7 | −0.735 | <0.0001 | ||
ACOT8 | −0.6153 | <0.0001 | ||
ACOT9 | −0.7035 | <0.0001 | ||
ACOX1 | Acyl-CoA oxidases | The first enzyme of the fatty acid beta-oxidation pathway | −0.5194 | 0.002 |
ACOX2 | Involved in the degradation of long branched fatty acids | −0.515 | 0.0022 | |
ACOX3 | Involved in the desaturation of 2-methyl-branched fatty acids in peroxisomes | −0.6116 | 0.0002 | |
ACAT1 | Acetyl-CoA transferases | Catalyses the last step of the mitochondrial beta-oxidation pathway | −0.497 | 0.0033 |
ACAA1 | Involved in the beta-oxidation system of the peroxisomes | −0.6186 | 0.0001 | |
ACAA2 | Catalyses the last step of the mitochondrial fatty acid beta-oxidation | −0.5374 | 0.0013 | |
ACAT2 | Intracellular cholesterol esterification | −0.736 | <0.0001 | |
CPT1A | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.6013 | 0.0002 |
CPT1B | −0.5074 | 0.0026 | ||
CPT1C | −0.4131 | 0.0169 | ||
CPT2 | −0.6003 | 0.0002 | ||
CRAT | −0.5916 | 0.0003 | ||
CROT | −0.5729 | 0.0005 | ||
FABP1 | Facilitate FFA transport across membranes | 0.538 | 0.0012 | |
SLC27A1 | −0.6785 | <0.0001 | ||
SLC27A3 | −0.7035 | <0.0001 | ||
SLC27A4 | −0.478 | 0.0003 | ||
SLC27A5 | −0.4923 | 0.0036 | ||
FABP7 | Cytoplasmatic FFA transport proteins | 0.5572 | 0.0008 | |
FABP2 | 0.5104 | 0.0024 | ||
FABP4 | −0.5084 | 0.0025 | ||
FABP12 | 0.6093 | 0.0002 | ||
FABP5 | −0.4686 | 0.006 | ||
PRKAA2 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | −0.6355 | <0.0001 |
PRKAB1 | Regulatory B1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.8456 | <0.0001 | |
PRKAB2 | Regulatory B2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.7574 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.6537 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | −0.5525 | 0.0009 | |
PRKAG1 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.734 | <0.0001 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | −0.4559 | 0.0077 | |
ALDH2 | Other fatty acid metabolism genes | Oxidizes aldehydes to generate carboxylic acids for use | −0.4078 | 0.0185 |
DECR1 | Accessory enzymes that participate in the beta-oxidation and metabolism of unsaturated fatty enoyl-CoA esters | −0.5792 | 0.0004 | |
ECHS1 | Involved in mitochondrial fatty acid beta-oxidation pathway | −0.5137 | 0.0022 | |
ECI2 | Mitochondrial enzyme involved in beta-oxidation of unsaturated fatty acids | −0.6487 | <0.0001 | |
HADHA | Catalyses the last three steps of mitochondrial beta-oxidation of long chain fatty acids | −0.4682 | 0.006 | |
MCEE | Involved in the degradation of odd chain-length fatty acids | −0.5745 | 0.0005 | |
MUT | −0.5805 | 0.0004 | ||
PPA1 | Catalyses the hydrolysis of pyrophosphate to inorganic phosphate | −0.5451 | 0.001 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.6344 | <0.0001 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.4335 | 0.0117 | |
GK2 | Key enzyme in the regulation of glycerol uptake and metabolism | 0.5577 | 0.0007 | |
GPD1 | Synthesis of triglycerides | −0.5872 | 0.0003 | |
GPD2 | −0.3556 | 0.0423 | ||
BDH2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | −0.5254 | 0.0017 |
HMGCS1 | −0.7764 | <0.0001 | ||
OXCT2 | Involved in ketone body catabolism. | 0.3795 | 0.0294 | |
HMGCL | Catalyzes the final step of leucine degradation and plays a key role in ketone body formation. | −0.6511 | <0.0001 | |
b) Adipogenis genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ADIPOQ | Adipokines and hormones | Involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic, and anti-inflammatory activities | −0.548 | 0.001 |
ANGPT2 | An inducer of fat uptake in adipose tissue for prevention of ectopic lipid deposition | −0.538 | 0.001 | |
RETN | A feedback regulator of adipogenesis | 0.438 | 0.011 | |
AGT | Encodes for angiotensinogen precursor angiotensin | −0.540 | 0.001 | |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.569 | 0.001 | |
FASN | PPARγ TARGETS | Fatty acid synthetase that catalyses the de novo biosynthesis of long-chain saturated fatty acids | −0.368 | 0.035 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.434 | 0.012 | |
FABP4 | Lipid transport protein in adipocytes | −0.508 | 0.003 | |
ADRB2 | Anti-adipogenesis | Beta-2-adrenergic receptor with lipolytic activity | −0.482 | 0.005 |
CDKN1A | A cyclin-dependent kinase inhibitor | −0.510 | 0.002 | |
CDKN1B | −0.678 | <0.0001 | ||
DDIT3 | A member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors that block adipogenesis | −0.731 | <0.0001 | |
FOXO1 | Transcription factor that inhibits lipogenesis | −0.483 | 0.004 | |
HES1 | −0.670 | <0.0001 | ||
LRP5 | A transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis | −0.492 | 0.004 | |
NCOR2 | Inhibits adipogenic differentiation by binding to PPARγ and represses the expression of PPARγ target genes | −0.743 | <0.0001 | |
SHH | Inhibits adipocyte differentiation | 0.565 | 0.001 | |
RUNX1T1 | Recruits a range of co-repressors to acts as a negative regulator of adipogenesis | −0.636 | <0.0001 | |
SIRT1 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.778 | <0.0001 | |
SIRT2 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.626 | <0.0001 | |
TAZ | A transcriptional co-repressor of PPARγ that attenuates adipogenesis | −0.738 | <0.0001 | |
WNT3A | Inhibitor of adipogenesis | 0.497 | 0.003 | |
VDR | Unliganded VDR can activate adipogenesis through increased lipid accumulation | −0.532 | 0.001 | |
TCF7L2 | Adipose specific knockout of Tcf7l2 leads to adipocyte hypertrophy and impaired lipolysis | −0.397 | 0.022 | |
TSC22D3 | Inhibitor of the adipogenic master regulator PPARγ | −0.657 | <0.0001 | |
NCOA2 | Anti-BAT tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | −0.704 | <0.0001 |
TWIST1 | Inhibit UCP-1 in brown adipocytes | −0.385 | 0.027 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | −0.703 | <0.0001 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.537 | 0.001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | −0.558 | 0.001 |
KLF2 | Negative regulator of adipogenesis | −0.568 | 0.001 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | −0.567 | 0.001 | |
AXIN1 | Pro-adipogenesis | Promoter of adipocyte differentiation | −0.799 | <0.0001 |
CCND1 | −0.458 | 0.007 | ||
CDK4 | −0.817 | <0.0001 | ||
CEBPA | −0.579 | 0.0001 | ||
CEBPB | −0.553 | 0.001 | ||
CEBPD | −0.369 | 0.034 | ||
E2F1 | −0.515 | 0.002 | ||
FGF1 | −0.450 | 0.009 | ||
FGF2 | −0.670 | <0.0001 | ||
IRS2 | 0.560 | 0.001 | ||
SFRP1 | −0.354 | 0.043 | ||
SLC2A4 | −0.369 | 0.034 | ||
LMNA | −0.810 | <0.0001 | ||
PPARG | −0.506 | 0.003 | ||
RXRA | Implicated in the development of dysfunctional white adipose tissue | −0.700 | <0.0001 | |
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.693 | <0.0001 |
DIO2 | Involved in the transcriptional regulation of brown adipogenesis | −0.791 | <0.0001 | |
INSR | Regulates metabolism in brown adipose tissue | −0.411 | 0.017 | |
IRS1 | Involved in the differentiation of brown adipocytes | −0.449 | 0.009 | |
NRF1 | Involved in brown adipose tissue thermogenic adaptation | −0.775 | <0.0001 | |
MAPK14 | Controls brown adipocyte differentiation | −0.715 | <0.0001 | |
PPARA | Regulators of brown adipogenesis/metabolism | −0.619 | 0.0001 | |
PPARD | −0.740 | <0.0001 | ||
PPARGC1B | −0.389 | 0.025 | ||
PRDM16 | −0.525 | 0.002 | ||
WNT5A | −0.458 | 0.007 | ||
SRC | Controls brown fat thermogenesis | −0.412 | 0.017 | |
SIRT3 | −0.745 | <0.0001 | ||
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | −0.521 | 0.002 |
BMP2 | −0.512 | 0.002 | ||
BMP4 | −0.709 | <0.0001 | ||
CEBPA | Required for differentiation of white adipocytes | −0.579 | 0.0004 | |
b) Adipogenis genes and glucose-dependent insulinotropic peptide receptor (GIPR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ADIPOQ | Adipokines and hormones | Involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic, and anti-inflammatory activities | −0.548 | 0.001 |
ANGPT2 | An inducer of fat uptake in adipose tissue for prevention of ectopic lipid deposition | −0.538 | 0.001 | |
RETN | A feedback regulator of adipogenesis | 0.438 | 0.011 | |
AGT | Encodes for angiotensinogen precursor angiotensin | −0.540 | 0.001 | |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.569 | 0.001 | |
FASN | PPARγ TARGETS | Fatty acid synthetase that catalyses the de novo biosynthesis of long-chain saturated fatty acids | −0.368 | 0.035 |
LIPE | In adipose tissue hydrolyses stored triglycerides to free fatty acids | −0.434 | 0.012 | |
FABP4 | Lipid transport protein in adipocytes | −0.508 | 0.003 | |
ADRB2 | Anti-adipogenesis | Beta-2-adrenergic receptor with lipolytic activity | −0.482 | 0.005 |
CDKN1A | A cyclin-dependent kinase inhibitor | −0.510 | 0.002 | |
CDKN1B | −0.678 | <0.0001 | ||
DDIT3 | A member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors that block adipogenesis | −0.731 | <0.0001 | |
FOXO1 | Transcription factor that inhibits lipogenesis | −0.483 | 0.004 | |
HES1 | −0.670 | <0.0001 | ||
LRP5 | A transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis | −0.492 | 0.004 | |
NCOR2 | Inhibits adipogenic differentiation by binding to PPARγ and represses the expression of PPARγ target genes | −0.743 | <0.0001 | |
SHH | Inhibits adipocyte differentiation | 0.565 | 0.001 | |
RUNX1T1 | Recruits a range of co-repressors to acts as a negative regulator of adipogenesis | −0.636 | <0.0001 | |
SIRT1 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.778 | <0.0001 | |
SIRT2 | Attenuate adipogenesis through PPARγ repressive acetylation | −0.626 | <0.0001 | |
TAZ | A transcriptional co-repressor of PPARγ that attenuates adipogenesis | −0.738 | <0.0001 | |
WNT3A | Inhibitor of adipogenesis | 0.497 | 0.003 | |
VDR | Unliganded VDR can activate adipogenesis through increased lipid accumulation | −0.532 | 0.001 | |
TCF7L2 | Adipose specific knockout of Tcf7l2 leads to adipocyte hypertrophy and impaired lipolysis | −0.397 | 0.022 | |
TSC22D3 | Inhibitor of the adipogenic master regulator PPARγ | −0.657 | <0.0001 | |
NCOA2 | Anti-BAT tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | −0.704 | <0.0001 |
TWIST1 | Inhibit UCP-1 in brown adipocytes | −0.385 | 0.027 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | −0.703 | <0.0001 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.537 | 0.001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | −0.558 | 0.001 |
KLF2 | Negative regulator of adipogenesis | −0.568 | 0.001 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | −0.567 | 0.001 | |
AXIN1 | Pro-adipogenesis | Promoter of adipocyte differentiation | −0.799 | <0.0001 |
CCND1 | −0.458 | 0.007 | ||
CDK4 | −0.817 | <0.0001 | ||
CEBPA | −0.579 | 0.0001 | ||
CEBPB | −0.553 | 0.001 | ||
CEBPD | −0.369 | 0.034 | ||
E2F1 | −0.515 | 0.002 | ||
FGF1 | −0.450 | 0.009 | ||
FGF2 | −0.670 | <0.0001 | ||
IRS2 | 0.560 | 0.001 | ||
SFRP1 | −0.354 | 0.043 | ||
SLC2A4 | −0.369 | 0.034 | ||
LMNA | −0.810 | <0.0001 | ||
PPARG | −0.506 | 0.003 | ||
RXRA | Implicated in the development of dysfunctional white adipose tissue | −0.700 | <0.0001 | |
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.693 | <0.0001 |
DIO2 | Involved in the transcriptional regulation of brown adipogenesis | −0.791 | <0.0001 | |
INSR | Regulates metabolism in brown adipose tissue | −0.411 | 0.017 | |
IRS1 | Involved in the differentiation of brown adipocytes | −0.449 | 0.009 | |
NRF1 | Involved in brown adipose tissue thermogenic adaptation | −0.775 | <0.0001 | |
MAPK14 | Controls brown adipocyte differentiation | −0.715 | <0.0001 | |
PPARA | Regulators of brown adipogenesis/metabolism | −0.619 | 0.0001 | |
PPARD | −0.740 | <0.0001 | ||
PPARGC1B | −0.389 | 0.025 | ||
PRDM16 | −0.525 | 0.002 | ||
WNT5A | −0.458 | 0.007 | ||
SRC | Controls brown fat thermogenesis | −0.412 | 0.017 | |
SIRT3 | −0.745 | <0.0001 | ||
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | −0.521 | 0.002 |
BMP2 | −0.512 | 0.002 | ||
BMP4 | −0.709 | <0.0001 | ||
CEBPA | Required for differentiation of white adipocytes | −0.579 | 0.0004 | |
Glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
c) Fatty acid metabolism genes and glucagon receptor (GCGR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACADSB | Acyl-CoA dehydrohgenases | It has the greatest activity towards the short branched chain acyl-CoA derivative | 0.3753 | 0.0314 |
EHHADH | One of the four enzymes of the peroxisomal beta-oxidation pathway | −0.3693 | 0.0344 | |
ACADL | One of the four enzymes that catalyse the initial step of mitochondrial beta-oxidation of straight-chain fatty acid | 0.3815 | 0.0285 | |
ACAD10 | Involved in the beta-oxidation of fatty acids in mitochondria | 0.4278 | 0.00130 | |
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | 0.3850 | 0.0269 |
ACSBG2 | 0.8244 | <0.0001 | ||
ACSL6 | 0.3643 | 0.0371 | ||
ACSM3 | 0.7245 | <0.0001 | ||
ACSM4 | 0.8426 | <0.0001 | ||
ACOT12 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | 0.8235 | <0.0001 |
ACOT6 | 0.8001 | <0.0001 | ||
CROT | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.4649 | 0.0064 |
SLC27A3 | Facilitate FFA transport across membranes | 0.6557 | <0.0001 | |
FABP1 | Cytoplasmatic FFA transport proteins | 0.7942 | <0.0001 | |
FABP2 | 0.8285 | <0.0001 | ||
FABP12 | 0.7868 | <0.0001 | ||
FABP6 | 0.7830 | <0.0001 | ||
PRKAA1 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.5241 | 0.0017 |
PRKAA2 | AMP-activated, alpha 1 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.6581 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.8138 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | 0.5291 | 0.0015 | |
PRKAG3 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.4442 | 0.0096 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.9809 | <0.0287 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.5013 | 0.0030 |
HMGCS2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | 0.8085 | <0.0001 |
OXCT2 | Involeved in ketone body catabolism | 0.7908 | <0.0001 | |
Glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
c) Fatty acid metabolism genes and glucagon receptor (GCGR) . | ||||
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
ACADSB | Acyl-CoA dehydrohgenases | It has the greatest activity towards the short branched chain acyl-CoA derivative | 0.3753 | 0.0314 |
EHHADH | One of the four enzymes of the peroxisomal beta-oxidation pathway | −0.3693 | 0.0344 | |
ACADL | One of the four enzymes that catalyse the initial step of mitochondrial beta-oxidation of straight-chain fatty acid | 0.3815 | 0.0285 | |
ACAD10 | Involved in the beta-oxidation of fatty acids in mitochondria | 0.4278 | 0.00130 | |
ACSBG1 | Acyl-CoA synthetases | Activate long- and medium-chain FFA for oxidation | 0.3850 | 0.0269 |
ACSBG2 | 0.8244 | <0.0001 | ||
ACSL6 | 0.3643 | 0.0371 | ||
ACSM3 | 0.7245 | <0.0001 | ||
ACSM4 | 0.8426 | <0.0001 | ||
ACOT12 | Acyl-CoA thioesterases | Regulate FFA oxidation in mitochondria and peroxisomes | 0.8235 | <0.0001 |
ACOT6 | 0.8001 | <0.0001 | ||
CROT | Fatty acid transport | Transport FFA into mitochondria for oxidation | −0.4649 | 0.0064 |
SLC27A3 | Facilitate FFA transport across membranes | 0.6557 | <0.0001 | |
FABP1 | Cytoplasmatic FFA transport proteins | 0.7942 | <0.0001 | |
FABP2 | 0.8285 | <0.0001 | ||
FABP12 | 0.7868 | <0.0001 | ||
FABP6 | 0.7830 | <0.0001 | ||
PRKAA1 | Fatty acid biosynthesis regulation | AMP-activated, alpha 2 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.5241 | 0.0017 |
PRKAA2 | AMP-activated, alpha 1 catalytic subunit: inhibits ATP-consuming biosynthetic pathways | 0.6581 | <0.0001 | |
PRKACA | Catalytic subunits of protein kinase A: promotes fat utilization | 0.8138 | <0.0001 | |
PRKACB | Catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase | 0.5291 | 0.0015 | |
PRKAG3 | Regulatory G1 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.4442 | 0.0096 | |
PRKAG2 | Regulatory G2 subunit of AMP-activated protein kinase: inhibits ATP-consuming biosynthetic pathways | 0.9809 | <0.0287 | |
GK | Triacylglycerol metabolism | Esterification of FFA with reduced FFA efflux | −0.5013 | 0.0030 |
HMGCS2 | Ketogenesis and ketone body metabolism | Involved in the synthesis and degradation of ketone bodies | 0.8085 | <0.0001 |
OXCT2 | Involeved in ketone body catabolism | 0.7908 | <0.0001 | |
d) Adipogenesis genes and glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
RETN | Adipokines and hormones | A feedback regulator of adipogenesis | 0.6892 | <0.0001 |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.8425 | <0.0001 | |
HES1 | Anti-adipogenesis | Inhibits adipocyte differentiation | −0.4395 | 0.0105 |
DLK1 | 0.7219 | <0.0001 | ||
SHH | 0.8773 | <0.0001 | ||
TCF7L2 | 0.6788 | <0.0001 | ||
WNT1 | 0.8179 | <0.0001 | ||
WNT3A | 0.8289 | <0.0001 | ||
RUNX1T1 | −0.4275 | 0.0131 | ||
NCOA2 | Anti-brown adipose tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | 0.5221 | 0.0018 |
WNT10B | It blocks brown adipose tissue development and expression of UCP-1. | 0.7189 | <0.0001 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | 0.5211 | 0.0019 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.8780 | <0.0001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | 0.6982 | <0.0001 |
GATA3 | Involved in white browning | 0.4522 | 0.0082 | |
KLF2 | Negative regulator of adipogenesis | 0.4318 | 0.0121 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | 0.6765 | <0.0001 | |
IRS2 | Pro-adipogenesis | Promoter of adipocyte differentiation | 0.6517 | <0.0001 |
CEBPB | 0.4369 | 0.0110 | ||
FGF1 | 0.3830 | 0.0278 | ||
SFRP5 | 0.6130 | 0.0001 | ||
WNT5B | 0.3917 | 0.0242 | ||
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.4830 | 0.0044 |
FOXC2 | 0.8443 | <0.0001 | ||
MAPK14 | 0.3981 | 0.0218 | ||
PPARA | Regulators of brown adipogenesis/metabolism | 0.7383 | <0.0001 | |
PPARD | 0.8281 | <0.0001 | ||
PPARGC1A | 0.6832 | <0.0001 | ||
UCP-1 | 0.5635 | 0.0006 | ||
PRDM16 | 0.7189 | <0.0001 | ||
SRC | Controls brown fat thermogenesis | 0.4412 | 0.0102 | |
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | 0.5625 | <0.0007 |
KLF15 | 0.6768 | <0.0001 |
d) Adipogenesis genes and glucagon receptor (GCGR) . | ||||
---|---|---|---|---|
Genes . | Family group . | Function . | Correlation coefficient . | P value . |
RETN | Adipokines and hormones | A feedback regulator of adipogenesis | 0.6892 | <0.0001 |
ADIG | Adipocyte-specific protein that plays a role in adipocyte differentiation | 0.8425 | <0.0001 | |
HES1 | Anti-adipogenesis | Inhibits adipocyte differentiation | −0.4395 | 0.0105 |
DLK1 | 0.7219 | <0.0001 | ||
SHH | 0.8773 | <0.0001 | ||
TCF7L2 | 0.6788 | <0.0001 | ||
WNT1 | 0.8179 | <0.0001 | ||
WNT3A | 0.8289 | <0.0001 | ||
RUNX1T1 | −0.4275 | 0.0131 | ||
NCOA2 | Anti-brown adipose tissue | Required with NCOA1 to control energy balance between white and brown adipose tissues | 0.5221 | 0.0018 |
WNT10B | It blocks brown adipose tissue development and expression of UCP-1. | 0.7189 | <0.0001 | |
RB1 | Molecular switch determining white vs. brown adipogenesis | 0.5211 | 0.0019 | |
NR0B2 | A negative regulator of PGC-1α expression in brown adipocytes | 0.8780 | <0.0001 | |
GATA2 | Anti-white adipose tissue | Suppressor of adipocyte differentiation | 0.6982 | <0.0001 |
GATA3 | Involved in white browning | 0.4522 | 0.0082 | |
KLF2 | Negative regulator of adipogenesis | 0.4318 | 0.0121 | |
KLF3 | Induction of Wnt10b and KLF3 decrease PPARγ expression | 0.6765 | <0.0001 | |
IRS2 | Pro-adipogenesis | Promoter of adipocyte differentiation | 0.6517 | <0.0001 |
CEBPB | 0.4369 | 0.0110 | ||
FGF1 | 0.3830 | 0.0278 | ||
SFRP5 | 0.6130 | 0.0001 | ||
WNT5B | 0.3917 | 0.0242 | ||
CREB1 | Pro-brown adipose tissue | Involved in the transcriptional regulation of brown adipogenesis | −0.4830 | 0.0044 |
FOXC2 | 0.8443 | <0.0001 | ||
MAPK14 | 0.3981 | 0.0218 | ||
PPARA | Regulators of brown adipogenesis/metabolism | 0.7383 | <0.0001 | |
PPARD | 0.8281 | <0.0001 | ||
PPARGC1A | 0.6832 | <0.0001 | ||
UCP-1 | 0.5635 | 0.0006 | ||
PRDM16 | 0.7189 | <0.0001 | ||
SRC | Controls brown fat thermogenesis | 0.4412 | 0.0102 | |
BMP7 | Pro-white adipose tissue | Promoters of white adipogenesis | 0.5625 | <0.0007 |
KLF15 | 0.6768 | <0.0001 |
Table reports existing positive and negative correlations of glucose-dependent insulinotropic peptide receptor (GIPR) and glucagon receptor (GCGR) with genes involved in fatty acid metabolism and adipogenesis.
Spearman correlation coefficients and corresponding P value are reported.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.